Novel 3,5-bis(arylidene)-4-piperidone dimers: Potent cytotoxins against colon cancer cells
摘要:
Two novel series of dimeric 3,5-bis(arylidene)-4-piperidones 7 and 8 were prepared as cytotoxic agents. A specific objective of this study was the discovery of novel compounds displaying potent anti-proliferative activities against colon cancers. Most of the compounds demonstrate potent cytotoxicity against HCT116 and HT29 colon cancer cell lines in which the IC50 values range from low micromolar to nanomolar values. In general, the majority of the compounds showed greater cytotoxicity and some degree of selectivity toward HCT116 cells compared to HT29 cells. Compound 9 in which the amidic carbonyl groups were excised was substantially less potent than 8a in both cell lines suggested that the amide groups are important components of the molecules for exhibiting cytotoxicity. Virtually all the compounds were more potent than a reference drug 5-fluorouracil which is used in treating colon cancers as well as a related enone curcumin. QSAR studies were undertaken and some guidelines for amplification of the project have been formulated. Flow cytometry analysis of a representative potent compound 7f revealed that it induces apoptosis in HCT116 cells. (C) 2013 Elsevier Masson SAS. All rights reserved.
CLEFMA—An anti-proliferative curcuminoid from structure–activity relationship studies on 3,5-bis(benzylidene)-4-piperidones
摘要:
3,5-Bis(benzylidene)-4-piperidones are being advanced as synthetic analogs of curcumin for anti-cancer and anti-inflammatory properties. We performed structure-activity relationship studies, by testing several synthesized 3,5-bis(benzylidene)-4-piperidones for anti-proliferative activity in lung adenocarcinoma H441 cells. Compared to the lead compound 1, or 3,5-bis(2-fluorobenzylidene)-4-piperidone, five compounds were found to be more potent (IC50 <30 mu M), and 16 compounds possessed reduced cell-killing efficacy (IC50 >50 mu M). Based on the observations, we synthesized 4-[3,5-bis(2-chlorobenzyl-idene-4-oxo-piperidine-1-yl)-4-oxo-2-butenoic acid] (29 or CLEFMA) as a novel analog of 1. CLEFMA was evaluated for anti-proliferative activity in H441 cells, and was found to be several folds more potent than compound 1. We did not find apoptotic cell population in flow cytometry, and the absence of apoptosis was confirmed by the lack of caspase cleavage. The electron microscopy of H441cells indicated that CLEFMA and compound 1 induce autophagic cell death that was inhibited by specific autophagy inhibitor 3-methyladenine. The results suggest that the potent and novel curcuminoid, CLEFMA, offers an alternative mode of cell death in apoptosis-resistant cancers. (C) 2010 Elsevier Ltd. All rights reserved.
Novel Conjugated Unsaturated Ketones with Submicromolar Potencies Towards some Leukemic and Colon Cancer Cells
作者:Swagatika Das、H. Inci Gul、Umashankar Das、Jan Balzarini、Stephen G. Dimmock、Jonathan R. Dimmock
DOI:10.2174/1573406414666181015142633
日期:2019.5.20
compounds to treat this devastating condition. Various alkylating anticancer drugs have been employed in the clinic for treating cancers. Unsaturated conjugated ketones are a group of alkylators which are of significant interest as potent antineoplastic agents. Objective: The goal of this study is to discover unsaturated conjugated ketones which are novel potent cytotoxins displaying growth-inhibitory
Structure activity relationship analysis of antiproliferative cyclic C5-curcuminoids without DNA binding: Design, synthesis, lipophilicity and biological activity
shortcomings. The synthesis of twenty cyclic C5-curcuminoids is described in this study in order to gain more insight into their anticancer structure-activity relationship (SAR). The design of their synthesis included four different cyclanones and five substituted aromatic aldehydes to form four, five-membered subgroups. These model compounds were evaluated in vitro for antiproliferative activity in an XTT
Phosphoryl Substituted 3,5-<i>Bis</i>(Arylidene)-4-Piperidones Posessing High Antitumor Activity
作者:I. L. Odinets、M. V. Makarov、O. I. Artyushin、E. Yu. Rybalkina、K. A. Lyssenko、T. V. Timofeeva、M. Yu. Antipin
DOI:10.1080/10426500701793246
日期:2008.1.14
3,5-Bis(arylidene)-4-piperidones and related compounds 1 possess anticancer and antioxidant activity (Scheme 1).1,2 Some of these compounds are also fluorescent, which makes possible to use them as dyes for tracing their cellular pathways during chemotherapy and as agents for photodynamic therapy.3 The important way to regulate the bioavailability and drug delivery of these compounds to target organs
3,5-双(亚芳基)-4-哌啶酮和相关化合物 1 具有抗癌和抗氧化活性(方案 1)。1,2 其中一些化合物还具有荧光性,因此可以将它们用作染料来追踪其细胞通路在化疗期间和作为光动力治疗的药物。3 调节这些化合物的生物利用度和药物输送到靶器官的重要方法是将不同的替代物 R1 引入哌啶酮部分的 N 原子。含磷基团作为此类改性剂是有前景的,并且可能有助于生物活性。因此,我们在本系列中研究了磷酸化亚芳基哌啶酮的合成方法和“结构-活性-荧光特性”关系。
Novel Biologically Active 1,3,2-Oxazaphosphinane Derivatives
作者:Anatolii E. Shipov、Galina K. Genkina、Pavel V. Petrovskii、Evgenii I. Goryunov、Michael V. Makarov